Seeger Weiss Files Lawsuit on Behalf of Estate of Henrietta Lacks Against Ultragenyx

On August 10th, 2023, the family of Henrietta Lacks, represented by Seeger Weiss partners Chris Seeger and Chris Ayers along with nationally renowned civil rights attorney Ben Crump, filed a lawsuit against Novato, California-based Ultragenyx in the United States District Court for the District of Maryland, alleging the multibillion-dollar biopharmaceutical corporation unjustly enriched itself by […]

August 11, 2023

On August 10th, 2023, the family of Henrietta Lacks, represented by Seeger Weiss partners Chris Seeger and Chris Ayers along with nationally renowned civil rights attorney Ben Crump, filed a lawsuit against Novato, California-based Ultragenyx in the United States District Court for the District of Maryland, alleging the multibillion-dollar biopharmaceutical corporation unjustly enriched itself by profiting from Mrs. Lacks’s genetic material without her family’s consent.

“The enduring legacy of Henrietta Lacks should be one of acknowledgment, respect, and restitution, not continued exploitation by companies like Ultragenyx,” said Seeger. “Their actions stand as a grim reminder of America’s history of medical racism and the urgent need to rectify these past wrongs. Our lawsuit aims to help the Lacks family reclaim their ancestor’s story and receive the justice and compensation they deserve.”

In 1951, Henrietta Lacks was diagnosed with cervical cancer in the racially segregated ward at Johns Hopkins Hospital. Under the guise of cancer treatment, doctors surgically extracted tissue samples from Mrs. Lacks without her knowledge or consent. These stolen cells were cultivated into the first immortal human cell line, known as HeLa cells, and have played a pivotal role in countless pioneering medical discoveries, from the polio vaccine to gene-mapping and in vitro fertilization.

Despite being well aware of the grossly unethical origins of the HeLa cell line, Ultragenyx chose to treat Henrietta Lacks’s body as a manufacturing tool, utilizing her cells as a factory for adeno-associated virus (AAV) vector-based gene therapy products without seeking consent from her family. The company’s continued exploitation of Mrs. Lacks’s stolen cells to reap massive profits denies her and her family basic human dignity.

“Ultragenyx’s decision to profit from Henrietta Lacks’s cells without permission from her family is a glaring example of a biotech company violating ethical boundaries for financial gain,” said Ayers. “Ultragenyx understands—indeed, acknowledges on its own website—that the HeLa cells it cultivates for profit today were stolen from Mrs. Lacks. The company’s business is nothing more than a perpetuation of this theft.”

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, organizations, and states and local municipalities across the U.S. that have been injured or defrauded on a massive scale.

Related News

August 22, 2025
Fifteen Seeger Weiss Attorneys Selected For Inclusion in the 2026 Edition of The Best Lawyers in America

Seeger Weiss LLP is proud to announce that 15 of its attorneys have been selected for inclusion in the 2026 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and […]

Read More
August 4, 2025
Lawdragon Names Five Seeger Weiss Partners to 2025 500 Leading Global Litigators List

Lawdragon has recognized five Seeger Weiss partners—Chris Seeger, Stephen Weiss, David Buchanan, Jennifer Scullion, and Parvin Aminolroaya—in their 2025 Lawdragon 500 Leading Global Litigators list. This annual guide honors lawyers who “assiduously work to resolve disputes between nations, bring justice for human rights abuses, address financial fraud that crosses borders and unearth stashed assets.” The […]

Read More
July 31, 2025
Seeger Weiss Founding Partner Christopher Seeger Appointed Plaintiffs’ Lead Negotiation Counsel in Johnson & Johnson Talcum Powder Litigation

Seeger Weiss founding partner Christopher Seeger has been appointed Plaintiffs’ Lead Negotiation Counsel in the Johnson & Johnson Talcum Powder Litigation by the Honorable Judge Rukhsanah L. Singh of the District of New Jersey. The multidistrict litigation includes nearly 60,000 pending cases of women who developed ovarian cancer after using Johnson & Johnson’s Baby Powder, […]

Read More